恒瑞医药(600276.SH)：HRS-2162注射液获得药物临床试验批准通知书

Group 1 - The core point of the article is that Heng Rui Medicine (600276.SH) has received approval from the National Medical Products Administration for clinical trials of HRS-2162 injection, a new generation muscle relaxant antagonist [1] - HRS-2162 injection is designed to counteract the pharmacological effects of muscle relaxants and facilitate the rapid recovery of muscle tone [1]